NV#20F1-30 | NV#20F1-39 | F6 | Combined | |
---|---|---|---|---|
Total number of sequences examined: | 9,177 | 4,394 | 12,173 | 25,744 |
Total size of examined sequences (bp): | 3,846,707 | 1,751,833 | 2,932,559 | 8,531,099 |
Total number of identified SSRs: | 353 | 174 | 1,074 | 1,601 |
Number of SSR containing sequences: | 327 | 161 | 970 | 1,458 |
Number of sequences containing more than 1 SSR: | 25 | 13 | 95 | 133 |
Number of SSRs present in compound formation: | 15 | 6 | 75 | 96 |
Repeat types | ||||
Di-nucleotide type: | 58 | 45 | 92 | 195 |
Tri-nucleotide type: | 237 | 102 | 914 | 1,253 |
Tetra-nucleotide type: | 54 | 25 | 47 | 126 |
Penta-nucleotide type: | 4 | 1 | 13 | 18 |
Hexa-nucleotide type: | 0 | 1 | 8 | 9 |
Number of ESTs per SSR: | 26.0 | 25.3 | 11.3 | 16.1 |
Kb sequence per SSR: | 10.9 | 10.1 | 2.7 | 5.3 |